R Scott Obach

10PUBLICATIONS
55CO-AUTHORS
Medical biochemistry - nucleic acidsPharmaceutical delivery technologiesInfectious diseasesToxicology (incl. clinical toxicology)Proteins and peptides
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Feb 14, 2022
Disposition of Nirmatrelvir, an Orally Bioavailable Inhibitor of SARS-CoV-2 3C-Like Protease, across Animals and Humans.

Heather Eng, Alyssa L Dantonio, Eugene P Kadar

|Nov 02, 2021
An oral SARS-CoV-2 Mpro inhibitor clinical candidate for the treatment of COVID-19.

Dafydd R Owen, Charlotte M N Allerton, Annaliesa S Anderson

|Jul 30, 2021
Static and Dynamic Projections of Drug-Drug Interactions Caused by Cytochrome P450 3A Time-Dependent Inhibitors Measured in Human Liver Microsomes and Hepatocytes.

Elaine Tseng, Heather Eng, Jian Lin

|Sep 16, 2020
Discovery of a Novel Inhibitor of Coronavirus 3CL Protease for the Potential Treatment of COVID-19.

Britton Boras, Rhys M Jones, Brandon J Anson

Pageof 2